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EXPLANATORY  MEMORANDUM 
Directive  89/622/EEC  on  the  approximation  of  the  laws,  regulations  and 
administrative  provisions  of  the  Member  States  concerning  the  label I ing 
of  tobacco  products<n,  adopted  on  13  November  1989,  harmonized  the 
regulations on  the  labelling of  tobacco  products,  taking  as  a  base  a  high 
level  of  health  protection. 
The  present  proposal. introduces  amendments  to  the existing Directive with 
a ,view  to  further  harmonizing  national  provisions  on  the  Iabeii ing  of 
tobacco  products. 
Like  Directive  89/622/EEC,  this  propos  a I  for  a  directive  has  as  its 
context  the  completion of  the  Internal  Market  in  1992. 
1.  SUMMARY  OF  THE  SITUATION 
Directive 89/622/EEC  provides  that  all  packets of  tobacco  products shall 
carry  a  general  warning:  "Tobacco  seriously  damages  health". 
In  addition  to  the  general  warning,  a  second,  specific  warning  is 
required  for  cigarette  packets.  To  this  end,  Member  States  are  required 
to  draw  up  national  lists  of  warnings  to  be  printed  on  an  alternating 
basis  on  cigarette  packets,  based  on  the  warnings  contained  in  the  Annex 
to  the  Directive.  The  Annex  contains  two  parts  :  part  A,  containing  two 
warnings  whIch  must  be  inc I  uded  on  the  nat iona I  I i sts  ("Smoking  causes 
cancer",  "Smoking  causes  heart  disease"),  and  part  B,  containing  14 
warnings  from  amongst  which  Member  States  may  choose  when  drawing  up 
their  I i st. 
Directive  89/622/EEC  also  provides  that  the  tar  and  nicotine  yields must 
be  indicated  on  cigarette  packets  and  specifies  the  ISO  standards  to  be 
used  for  measurement  and  verification of  these yields. 
In  other  words,  the  harmonization  provided  for  by  the  Directive  Is  based 
on  ful I  label I ing  of  cigarette packets,  cigarettes representing more  than 
90%  of  the  total  market  in  tobacco  products  in  the  Community.  As  in  most 
Member  States,  the  labelling  laid  down  In  the  Directive  for  tobacco 
products  other  than  cigarettes  is  I imited  to  the  general  warning. 
Moreover,  in  the  absence  of  a  recognized  measurement  method,  the  tar  and 
nicotine  yields are sti I I  not  shown  for  any  other  tobacco  products. 
The  situation as  regards  national  provisions on  the  label I ing  of  tobacco 
products  has  been  radically  altered  by  Directive  89/622/EEC,  due  to  come 
into  force  on  31  December  1991. 
Member  States  are  on  the  point  of  adopting  prov1saons  to  transpose  this 
Directive  into national  law.  To  date,  this  transposition  shows  a  certain 
delay  in  relation  to  the  deadlines  set  out  in  Article  9,  paragraph  1,  of 
the  text  requesting  Member  States  to  notify  the  European  Commission  of 
measures  taken  to  comply  with  this  Directive  (only  three  notifications 
have  been  officially received).  However,  no  Member  State  has  cal led  into 
question  the  deadline  for  Implementation  specified  in  Article  9(2),  (31 
December  .  1991). 
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Pending  Implementation,  the  situation  is as  follows 
In  most  Member  States  which  have  regulations  In  this  field,  tobacco 
products  other  than  clgaret\tes  are  covered,  at  least  partially,  by  a 
\ 
single warning  or  various different  warnings. 
A  general  warning  on  the  harmfulness  of  the  product  to  health  is 
obligatory  on  all  tobacco  products  in  France  ("Abuse  is  dangerous"), 
Por tuga I  ("Tobacco  damages  he a It h  and,  in  part i cuI ar,  causes  cancer") , 
Belgium  ("Tobacco  damages  health")  and,  more  recently,  Greece  ("Tobacco 
seriously  damages  health").  In  Spain,  optional  warnings  are  applicable 
to  all  tobacco  products  ("Smoking  seriously  damages  health",  "Smoking 
causes  cancer",  "Smoking  causes  heart  disease",  "Smoking  when  pregnant 
harms  your  baby").  In  Germany  a  general  warning  ("Tobacco  damages  your 
he a 1  t h")  covers  a I I  smoking  tobacco  products.  In  the  Net her I  ands  a 
general  warning  covers  cigarettes  and  rolling  tobacco  ("Smoking  damages 
health.  It  can  cause  lung  cancer  and  heart  disease").  In  the  United 
Kingdom,  alternating  warnings  are  applied  to  cigarettes  and  rolling 
tobacco  ("Smoking  can  cause  fatal  diseases",  "Smoking  can  cause  heart 
disease",  "Smoking  when  pregnant  can  inJure  your  baby  and  cause  premature 
birth",  "Stopping  smoking  reduces  the  risk  of  serious  diseases", 
"Smoking  can  cause  lung  cancer,  bronchitis  and  other  chest  diseases", 
"More  than  30  000  people  die  each  year  In  the  United  Kingdom  from  lung 
cancer").  In  Ireland  the  regulations  provide  for  a  general  warning 
("Smoking  is  a  health  hazard")  as  wei I  as  alternating  warnings  for 
c 1  garet tes  and  ro I I i ng  tobacco  ("Smoking  causes  cancer",  "Smokers  die 
younger",  "Smoking  kills",  "Smoking  causes  heart  disease">.  and  before 
the  banning of  chewing  tobaccos,  a  warning  ("This  product  can  cause oral 
cancer")  was  applied  to  these  products.  In  Denmark  there  Is  a  general 
warning  for  use  on  cigarette packets only  ("Tobacco  damages  health").  In 
Italy and  Luxembourg  no  regulations  have  yet  been  adopted. 
2.  BASIS  FOR  THE  COMMUNITY  ACTION 
During  discussion  and  adoption  of  Directive 89/622/EEC  the  Member  States 
had  asked  the  Commission  to  present  a  new  proposal  as  soon  as  technically 
possible  containing  additional  provisions  for  the  Iabeii ing  of  tobacco 
products  other  than  cigarettes  with  appropriate  warnings.  The 
Commission,  after  rece1v1ng  the  opinion  of  the  Committee  of  Cancer 
Experts  of  the  Europe  Against  Cancer  Programme,  has  thus  decided  to 
introduce  the  amendments  necessary  to  provide  for  specific  warnings  for 
tobacco  products other  than cigarettes. 
Additionally,  in  1  ine  with  the  agreement  established with  the Counci 1 for 
the  regular  updating of  the  list of  optional  warnings  in  the  Annex  to  the 
Directive,  which  have  so  far  applied  to  cigarettes  only,  the  Commission 
is  taking  the opportunity  to  supplement  this  I 1st. 
Finally,  the  proposal  seeks  to  harmonize  Member  States'  national 
provisions  concerning  oral  moist  snuff  tobaccos.  Given  that  the  Member 
States  most  affected  by  these  new  products  have  banned  them,  the  measure 
provided  for  in  this present  proposal  i~ also based on  a  total  ban. 
The  legal  basis 
EEC  Treaty,  as 
paragraph  3  of 
protection. 
employed  for  the  present  proposal  is Article  100a  of  the 
it  was  for  the  earlier  Directive.  In  keeping  with 
this  Article,  it  takes  as  a  basis  a  high  level  of - 4  -
3.  THE  PROPOSED  AMENDMENTS 
These  come  under  three distinct  headings: 
a.  Specific warnings  for  tobacco  products other  than cigarettes. 
As  stated earlier,  the Commission  had  given  an  undertaking  to  the  Counci I 
to  propose  an  instrument  establishing  specific  warnings  for  tobacco 
products other  than  cigarettes. 
This  proposal  is  based  on  the  opinion  of  the  scientific experts,  and  in 
particular  on  the  opinion  of  the  Committee  of  Cancer  Experts  of  the 
Europe  Against  Cancer  Programme,  as  wei  I  as  on  the  opinion  of  the_ 
International  Agency  for  Research  on  Cancer  (IARC). 
From  the  technical  and  scientific  point  of  view,  and  for  the  purposes  of 
their  specific  labelling,  tobacco  products other  than  cigarettes  need  to 
be  divided  into  three distinct  groups. 
The  technical  requirements  concerning  the  presentation  of  the  specific 
warnings  on  the  packagings of  these  three  types of  products  correspond  to 
the  flexible  approach  established  in  Article  4(5)  of  Directive 89/622/EEC 
for  tobacco  products other  than cigarettes. 
These  groups  are: 
-Rot I ing  tobaccos.  Consumption  of  these  products  is simi tar  in  nature  to 
that  of  cigarettes  and  carries  the  same  health  risks.  Consequently,  the 
unit  packets  of  these  products  should  carry  the  same  warnings  as  those 
I isted  for  cigarettes  in  the  Annex  to Directive 89/622/EEC. 
- Other  smoking  tobaccos  (pipe  tobacco,  cigars,  cigari I los,  etc.).  The 
consumption  of  these  products  has  certain  special  characteristics. 
Lacking  of  enough  scientific  data  available  it  does  not  seem  necessary, 
as  regards  the  Iabeii ing  of  these  products,  to  apply  warnings  I inking 
their  use  to  heart  disease.  However,  all  the  other  warnings  established 
for  cigarettes and  rot I ing  tobacco  are applicable. 
- Smokeless  tobacco  products  (e.g.  chewing  tobacco  and  snuff).  These 
products  have  only  a  very  small  market  in  Europe.  Their  consumption,  by 
mouth  or  nose,  has  quite  different  characteristics  from  that  of  smoking 
tobacco.  Chewing  tobacco  and  snuff  are  products  with  a  long  tradition of 
manufacture  and  use  in  Europe.  Since  the  1920's,  however,  their  use  has 
been  in  steady  dec I ine,  to  the  point  where  they  now  have  virtually  no 
market  outside  certain  soc io-profess iona I  groups  (seafarers,. miners  and 
sectors  of  the  army)  and  regions.  Moreover,  on  the  basis  of  available 
epidemiologic  studies,  it  has  been  prov~d that  these  products  can  provoke 
cancer.  Consequently,  the  approach  adopted  consists  of  a  specific 
warning  on  the  potential  carcinogenicity of  the  product. 
In  this  context,  a  distinction  needs  to  be  made  between  smokeless 
tobaccos  such  as  chewing  tobacco  and  snuff,  and  certain  new  products  -
oral  moist  snuff  tobaccos.  Section  c  below  is  devoted  to  these  new 
products. - 5  -
b.  Warning  concerning  the  addiction caused  by  the  use of  tobacco  products 
Jho  Cotmnluolon  conoldn1 n  thnt  lhln  ptoponal  ror  1111  nmnndmant  orrnra  an 
appropriate  opportunity  to  introduce  a  warning  concerning  the  addiction 
caused  by  the  use of  tobacco  products. 
Addiction  is a  characteristic  inherent  in  any  tobacco  product,  due  to  the 
presence  of  nicotine.  Nicotine,  as  has  recent I  y  been  estab I i shed  by, 
inter  alia,  the  Surgeon  General  of  the  United  States  in  his  1988  report 
"The  Hea I th  Consequences  of  Smoking  - Tobacco  Addict ion",  has  a II  the 
properties  associated  with  the  definition  of  a  drug:  neurophysiological 
stimulation,  tolerance,  physical  and  psychological  addiction,  permanent 
risk of  recidivism after  giving  up,  etc. 
The  inclusion  of  this  message  in  the  I ist  of  warnings  I iable  to  be 
carried  on  alI  tobacco  products  is  important  in  that  It  gives  the 
consumer  objective  Information  concerning  the  characteristics  of  the 
product.  Moreover,  the  message  should  have  a  powerful  dissuasive  effect 
on  persons  who  have  not  yet  started  using  tobacco  regularly,  and  young 
persons  in  particular. 
c.  Moist  snuff  tobaccos  for  oral  use 
This  proposa 1  for  a  directIve  a 1  so  aims  to  harmonize  Member  States· 
national  provisions on  oral  moist  snuff  tobaccos. 
The  first  action  plan  of  the  "Europe  against  cancer"  programme  (1987-
1989)  already  attracted  attention  to  certain  new  tobacco  products  which 
have  recently  been  put  on  the  market.  The  principal  producers  of  this 
new  product  on  the world  market  are  the  American  group  USTC-United  States 
Tobacco  Company  and  the  Swedish  company  Svenska  Tobaks  A.B. 
In  1985,  the American  group  opened  a  factory  near  Glasgow,  In  the  United 
Kingdom,  which  employed  19  people. 
Following  the  adoption  by  the  British  Authorities  in  December  1989  of  a 
measure  banning  the  production  and  marketing of  this  product,  which  came 
into effect  on  13  March  1990,  the  factory closed on  the  same  date. 
As  concerns  the marketing of  this  product  in  the other  Member  States,  the 
situation  is  as  follows: 
Ireland  banned  this product  in  1988; 
In  Denmark,  the  Netherlands  and  Germany,  this  product  has  not  been 
marketed  although  it  is  starting  to  be  known  among  young  people  of 
these countries; 
Belgium  has  informed  us of  a  forthcoming  law  banning  this product; 
In  other  Member  States,  this product  is  not  known. 
On  several  occasions,  the  Health Authorities of  the  Member  States and  the 
services  of  the  European  Commission  have  been  warned  by  numerous 
organizations  and  scientists  of  international  reknown,  who  have  drawn 
attention  to  the  dangers  of  this  new  type  of  smokeless  tobacco  product 
for  oral  use. 
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Studies  published  by  the  International  Agency  for  Research  on  Cancer  in 
Lyon  in  1985  ("Monographs  on  the  evaluation of  the  risks of  carcinogenic 
substances  to  humans"  - Volume  37)  and  the  report  of  the  Surgeon  General 
of  the  United  States  in  1986  show  that  significant  amounts  .of 
carcinogenic substances  are present  in  oral  moist  snuff  tobaccos,  such  as 
Polonium-210  (known  for  its carcinogenic effects by  irradiation),  and  two 
categories  of  highly  carcinogenic  agents  polycyclic  aromatic 
hydrocarbons  and  nitrosamines.  The  nitrosamines  present  in  moist  snuff 
tobacco  products are more  highly  concentrated  than  in  chewing  tobacco. 
Moist  snuff  tobacco  contains  from  1 ,6  to  135  mg  per  kg  of  NNN  and  from 
0,1  to  14  mg  per  kg  of  NNK,  two  substances  of  the  carcinogenic 
nitrosamine  category  presenting  the  highest  concentration.  As  a 
comparison,  in  the  United  States,  food  and  drink  must  not  contain  more 
than  0,01  mg  per  kg  of  nitrosamines.  Therefore,  the  principal 
carcinogenic  substances  in  moist  snuff  tobacco  are  10.000  times  higher 
than  those  allowed  in  food  products  and  100  times  higher  than  in 
cigarettes. 
' 
As  concerns  nicotine,  substance  leading  to  addiction,  the  studies 
referred  to  show  that  in  moist  snuff  tobacco,  the  concentration  ranges 
from  4,6  to  15  mg  per  gram.  Recent  studies  tend  to show  that  exposure  to 
nicotine  is  more  important  for  these  products  than  for  cigarettes  with  a 
higher  impact  on  heart  rythm  and  blood  pressure.  The  concentration  of 
nicotine  in  the  blood  is  maintained  longer  in  consumers  of  moist  snuff 
tobacco,  due  to  the  fact  that  the  nicotine  is  introduced  directly  into 
the  blood  stream  through  the oral-cavity. 
In  accordance  with  the  conclusions  referred  to,  these  new  products 
provoke  cancers  of  the  mouth,  and  increased  risks of  cancer  of  the  nasal 
cavity,  the  pharynx.  the  I  arynx  and  even  other  organs  such  as  the 
pancreas  and  the  urinary  tract.  For  pregnant  women,  moist  snuff  tobacco 
due  to  its passage. through  the  placenta,  Is  harmful  to  the  foetus. 
In  1988  the  first  European  Conference  on  Tobacco  or  Health  (Madrid,  7-
11  November),  organized  jointly  by  WHO  and  the  European  Community, 
produced  a  ten-point  strategy  for  a  "Europe  without  tobacco",  point  8  of 
which  recommends  banning  alI  new  tobacco  products containing nicotine. 
Finally,  in  1989  and  1990,  the  European  Committee  of  Cancer  Experts 
renewed  Its  recommendations  along  these  same  lines  on  the  basis  of  the 
epidemiological  studies on  the  subject. 
The  situation described  above  as  concerns  the  marketihg of  these  products 
in  the  Member  States  shows  that  those  most  exposed  have  a 1 ready  taken 
measures  to·  ban  this  product.  The  others,  where  it  is  still  little 
known,  even  unknown,  have  not  yet  reacted. 
This  new  product,  which  has  started  to  be  distributed  on  the  market  of 
certain  Member  States,  is  marketed  in  such  a  way  as  to  attract  young 
consumers. 
Faced  with  existing scientific data,  and  at  the  reQuest  of  the  Committee 
of  Cancer  Experts,  the  European  Commission  has  found  itself  confronted 
with  the  need  to  take  preventive  measures  concerning  these  products. 
After  examining  the  problem,  It  has. taken  note  that  the  only  effective 
preventive measure  against  the  consumption  of  this product,  is  to  ban  it, 
before  it  Is  too widely  spread  in  Community  territory. - 7  -
Reinforcing  the  labelling of  moist  snuff  tobacco  products,  for  example  a 
special  warning  addressed  to  young  people,  does  not  seem  to  be  a 
sufficient  measure  for  their  protecti6n  taking  account  of  the  attraction 
of  this product  as  shown  by  several  statistics. 
The  Community  system  for  Information and  the  adoption of measures  banning 
dangerous  substances  In  food  products  does  not  seem  to  be  applicable  for 
these  new  tobacco  products.  This  system,  based  on  the  presence  of 
substances  in  food  products  and  not  on  the  product  Itself,  cannot 
constitute  a  valid  basis  for  action  In  this  case  which  concerns  a  new 
non-food  product  characterized by  high  presence of  an  important  number  of 
carcinogenic substances. 
Moreover,  the  Federal  Justice  Authority of  the  United  States declared  in 
1986  that  the  only  measure  capable  of  slowing  down  the  expansion  of  the 
product  in  the  United  States  would  be  a  ban  If  consumption  was  not 
already  so widespread  in  this country. 
Furthermore,  the  establishment  of  common  technical  standards  providing 
for  maximum  content  of  carcinogenic  substances  is  not  technically 
feasable.  Although  it  is  possible  through  chemical  analysis·  to  measure 
composants  of  the  product,  there  are  to  date  no  measures  in  standards 
. recognised  at  international  level  which  would  Insure  at  the  time  of 
manufacture  the  drastic  product ion  of  dangerous  substances· contained  in 
this  product.  Besides,  the  main  effect  of  this  new  product  being  to 
attract  and  then  make  young  people  addictive  to  nicotine,  the 
establishment  of  such  technical  norms  would  not  offer  an  efficient 
protection  to  them. 
The  European  Commission  has  also examined  the  possibi I ity of  a  ban  of  the 
sale  of  these  products  to  young  people  under  the  age  of  18  years. 
Nevertheless,  this measure  would  not  be  sufficient  to prevent  consumption 
by  younger  people,  once  the  product  was  in  circulation.  It  would  even 
risk  having  the  inverse effect,  inciting young  people  to consumption. 
The  European  Commission  has,  as  a  result,  come  around  to  the  position 
adopted  by  two  Member  States  <very  soon  three)  and  proposes  the  ban  of 
the  Introduction of  this product  on  the Community  market. 
The  European  Commission  considers  that  the  preventive  action  for  tobacco 
products  already  existing  for  many  years,  and  firmly  fixed  in  the 
habits  of  European  consumers,  aims  to  reduce  significantly  their 
consumption  through  a  series  of  measures  foreseen  in  the  successive 
"Europe  against  cancer"  action  plans.  This  action  is  concentrated 
principally  on  smoking  tobacco  taking  account  of  the  fact  that  smokeless 
tobacco made  traditional Jy,  as pointed out  in  point  a),  is decreasing  and· 
is  limited  to  certain socio-professional  groups  or  to  certain  regions of  ' 
the  European  Community. 
On  the  contrary,  as  concerns  new  products scientifical Jy  recognised  to be 
harmful  and  which  are  not  widespread  among  European  consumers,  the  most 
efficient  cancer  prevention  measure  is  the  ban  of·  this  broduct,  before 
the  economic  and  personal  interests of  the  consumers  are affected. 
This  conviction  of  the  Commission  has  been  reinforced  by  the  fact  that, 
according  to  alI  available  statistical  data,  this  product  has  a 
particular attraction  for  young  people .. - 8  -
Thus,  In  the  United  States,  at  the beginng  of  the seventies,  less  than  1% 
of  young  people  consumed  smokeless  tobacco  In  any  form.  In  the  United 
States  the  consumption  of  moist  snuff  tobacco  has  increased  15  times 
since  1970  among  young  boys  from  17  to 19  years. 
The  quantity  of  moist  snuff  tobacco  has  Increased  by  30,7 million  pounds 
in  1981  to  42,6  million  pounds  In  1989  and  Is  calculated  at  46  million 
for  1990. 
In  Sweden,  the  consumption  of  smokeless  tobacco  has  dropped  by 
approximately  75%  between  1920  and  1986.  But  although  the  consumption  of 
moist  snuff  tobacco  was  10%  In  1976,  among  young  people  from  18  to  24 
years,  It  reached  37%  in  1986  among  young  people  from  16  to  24  years. 
Finally,  the  justification  made  by  the  British  Authorities  in  their 
notification  (No  89/0192/UK)  in  the  framework  of  the  Directive 83/189/EEC 
of  their  project  for  the  regulation  banning  the  production  and  the 
marketing  of  moist  snuff 'tobacco  led  the  Commission,  on  30  October  1989, 
to  not  oppose  the  British  regulation.  It  has,  in  the  same  connection, 
dropped  the  complaint  lodged  against  the  United  Kingdom  by  US-Tobacco 
I  nternat iona I. 
The  existence  of  the  ban  of  this  product  In  the  two  Member  States 
confronted  with  this  problem  has  reinforced  the  conviction  of  the 
necessity  of  proposing  the  harmonization  In  this  direction  of  national 
legislation  applicable  to  this  product  of  which  the  dangers  for  human 
health  are evident. 
The  data  which  have  served  as  a  base  for  the  preparation  of  this 
proposal  figure  in  the  studies  and  reports  for  which  complete  references 
are given  in  annex. - 9  -
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COMMENTS  ON  THE  ARTICLES 
Article 1 
1.  An  amended  version of  Article 2 of  the  Directive. 
This  Article  defines  tobacco  products  for  the  purposes  of  their 
labelling,  but  excludes  oral  moist  snuff  tobaccos,  for  which  a  specific 
definition  is  introduced.  The  aim  of  this  amendment  is  to  define  clearly 
these  new  products whose  marketing  is  prohibited  by  the  ~ew Article Sa. 
2.  An  amended  version of  Article  4 of  the  Directive. 
The  amendment  concerns  the  specific  warnings  introduced  in  respect  of 
tobacco  products other  than cigarettes. 
A  distinction  is  made,  in  a  new  paragraph  2,  between  three  groups  of 
products with  differing  label I lngs: 
Ro I I i ng  tobaccos.  The  specific  warnIngs  a I ready  estab I I  shed  for 
cigarettes  in  the  Annex  to  the  Directive  are  ·applicable  to  these 
products. 
Cigars,  cigarillos,  pipe  tobacco  and  smoking  tobacco  products  other 
than  cigarettes  or  rolling  tobacco.  The  same  warnings  apply  to 
these  products  as  to cigarettes,  with  the  exception of  warning  No  2 
in  part  A of  the  Annex,  w~ich concerns  heart  disease. 
Smokeless  tobacco  products.  This  group  refers  in  particular  to 
snuff  and  chewing  tobacco.  One  warning only  is  proposed  :  "Can  cause 
cancer". 
In  addition,  the  rules  on  the  establishment  by  Member  States of  national 
I ists of  warnings  for  cigarettes as  wei I  as  the  rules on  the  frequency  of 
the  appearance  of  the  different  messages  are  extended  to  a I I  smoking 
tobaccos. 
The  purpose  of  amending  Article 4{5)  of  the Directive  is  to extend  to  the 
new  warnings  the  provisions  concerning  the  technical  characteristics  to 
be  followed  in  the  printing  or  affixing  of  warnings  on  tobacco  products 
other  than  cigarettes.  Given  the  nature  of  these  products  and  of  their 
packaging  a  flexible  approach  Is  called  for  here,  as  was  the  case  in  the 
former  paragraph  5  concerning  the  general  warning  on  tobacco  products 
other  than  cigarettes.  This  provision  thus  takes  account  of  the  great 
diversity  In  the  packaging  of  products  other  than  cigarettes  and  of  the 
specific characteristics of  their  presentation on  the market. 
3.  Technical  amendment  of Article 5 
4.  Introduction  of  a  new  Article  Sa  prohibiting  the  marketing  of  oral 
moist  snuff  tobaccos.  The  definition  of  the  product  covers  at 1  the 
existing  forms  in  which  this  new  product,  mainly  known  in  the  countries 
concerned  as  "skoal  bandit"  or  "moist  snuff",  is marketed.  The  definition 
excludes  traditional  products such  as  chewing  tobacco  and  snuff. - 12  -
5.  This  paragraph  Introduces  amendments  to  the  Annex  to the  Directive. 
The  amendments  to Article  4  also ental I  amending  the  title of  the  Annex. 
Henceforth,  the  Annex  will  serve  as  the  basis  for  warnings  applicable  to 
alI  smoking  tobacco  products. 
A  new  optional  warning,  No  15,  Is  added  to  part  B of  the  Annex:  "Smoking 
causes  addiction". 
This  Joins  the  list  of  warnings  from  amongst  which  Member  States  may 
choose  when  drawing  up  their  lists of  warnings  for  the  var lous  types  of 
smokTng  tobacco  products. 
Articles 2.  3  and  4 






Proposal  for  a 
QQUNCIL  DIRECTIVE 
amending  Directive 89/662/EEC  on  the approximation 
of  the  laws.  regulations and  administrative provisions 
of  the Member  States concerning  the  labelling of  tobacco  products 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Having  regard  to  the Treaty establishing  the  European  Economic  Community, 
and  In  particular Article  100a  thereof, 
Having  regard  to  the  proposal  from  the Commlssion,1 
In  cooperation with  the  European  Pari iament,2 
Having  regard  to  the opinion of  the  Economic  and  Social  Commltt~~.3 
Whereas  there  are  differences  between  the  laws,  regulations  and 
administrative  provisions  of  the  Member  States  on  the  label I ing  of 
tobacco  products;  whereas  these  differences  are  I ikely  to  constitute 
barriers  to  trade  and  to  impede  the  establishment  and  operation  of  the 
internal  market; 
Whereas  these possible barriers should  be  eliminated and  whereas,  to  that 
end,  the  marketing  and  free  movement  of  tobacco  products  should  be  made 
subject  to common  rules  concerning  label I lng• 
Whereas  such  common  rules  must  take  due  account  of  publ lc  health 
protection,  and  of  the  protection  of  young  persons  In  particular,  taking 
as  a  base  a  high  level  of  protection,  according  to Article  100a(3)  of  the 
Treaty• 
Whereas  the  Counc i I  and  the  repre.sentat i ves  of  the  Governments  of  the 
Member  States,  meeting  within  the  Counci I,  In  their  resolution of  7  July 
1986  on  a  programme  of  action  of  the  European  Communities  against 
cancer,4  set  for  this  programme  the  objective  of  contributing  to  an 
improvement  of  the  health  and  Quality  of  life  of  citizens  within  the. 
Community  by  reducing  the  number  of  cancers  and  whereas  they  have  for 
this  purpose  identified  a  fight  against  the  use of  tobacco  products  as 
their  prime objective; 
Whereas,  for  the  purposes  of  providing  objective  information  on  the 
risks  ental led  In  tobacco  consumption,  Counci I  Directive  89/622/EEc5 
established  a  general  warning  to  be  carried on  the  unit  packaging  of  alI 
tobacco  products,  together  with  additional  warnings  exclusively  for 
cigarettes; 
Whereas  the  Commission,  at  the  reQuest  of  the 
propose  an  amendment  to  Directive  89/622/EEC 
additional  warnings  to  be  carried  on  the  unit 
products other  than cigarettes; 
Counc I I ,  under took  to 
so  as  to  establish 
packaging  of  tobacco 
Whereas  scientific experts  are  of  the  opinion  that  all  tobacco  products 
carry  health  risks; 
OJ  No  c  184,  23.7 .1986,  p.  19. 
OJ  No  L 359,  8.12 .1989,  p.  1 . Whereas,  In  relation  to  their  effects on  health  and  for  the  purposes  of 
their  labelling,  a  distinction  needs  to  be  made  between  smoking  tobacco 
products  and  smokeless  tobacco  products; 
Whereas  rolling  tobaccos carry  the  same  health  risks as cigarettes and  it 
is  therefore  appropriate  that  the  specific  warnings  selected  for 
cigarettes should also apply  to  rol I ing  tobaccos; 
Whereas  other  smoking  tobacco  products  carry  similar  health  risks  to 
those  carried  by  cigarettes,  but  there  are  still  reservations  concerning 
their  contribution  to  heart  disease;  whereas  these  products  should 
therefore  be  required  to  carry  the  specific  warnings  selected  for 
cigarettes  and  rolling  tobacco,  with  the  exception  of  the  warning 
concerning  heart  disease; 
Whereas  i t  has  been  proved  that  smoke I  ess  tobacco  products  can  provoke 
cancer  and  that,  consequently,  they must  be  subject  to a  specific warning 
on  tobacco  products; 
Whereas  scientific  experts  are  of  the  opinion  that  the  addiction  caused 
by  tobacco  consumption  constitutes  a  danger  meriting  a  specific  warning 
on  every  tobacco  product; 
Whereas,  moreover,  new  smokeless  tobacco  products  - moist  snuff 
designed  for  oral  use,  which  have  appeared  recently  on  the  market  in 
certain  Member  States,  exercise  a  particular  attraction  for  young 
persons,  and  whereas  the  Member  States most  exposed  to  this  problem  have 
already  placed  total  bans  on  these  new  tobacco  products  or  are  about  to 
do  it; 
Whereas  there  are  differences  between  the  laws,  regulations  and 
administrative  provisions  of  the  Member  States  in  respect  of  oral  moist 
snuff  tobaccos.  and  whereas  these  products  therefore  need  to  be  made 
subject  to  common  rules; 
Whereas  there  is  a  real  risk  that  oral  moist  snuff  tobaccos  could  be 
used,  particularly  by  young  persons,  as  substitutes  for  smoking  tobacco 
products,  causing  nicotine  addIction,  if  restrictive  measures  are  not 
taken  in  time; 
Whereas,  in  accordance  with  the  conclusions  of  the  studies 
the  International  Agency  for  Research  on  Cancer,  oral 
tobaccos  contain  particularly  large  quantities  of 
substances,  and  whereas  these  new  products  cause  cancer  of 
particular; 
conducted  by 
moist  snuff 
carcinogenic 
the  mouth  in 
Whereas,  the  sales  bans  for  moist  oral  snuff  already  adopted  by  two 
Member  States  have  a  direct  impact  on  the  establishment  and  operation of 
the  internal  market,  hence  the  necessity  of  approximate  the  laws  of 
Member  States  in  this  subject  taking  as  a  base  a  high  level  of 
protection,  the only  appriopriate measure  being  a  total  ban, 
HAS  ADOPTED  THIS  DIRECTIVE: - 15  -
Article  1 
Directive 89/622/EEC  is .hereby  amended  as  follows: 
1.  Art lcle  2- is amended  as  follows: 
(a)  Point  1  is  replaced  by  the  following: 
"(1)  "tobacco  products" means  products  for  the  purpose  of  smoking, 
sniffing,  sucking .or  chewing,  with  the exception of oral  moist  snuff 
tobaccos,  inasmuch  as  they are,  even  partly,  made  of  tobacco;". 
(b)  The  following  point  (4)  Is  added: 
"(4)  "oral  moist  snuff  tobaccos"  means  all  products  made  wholly  or 
partly of  moistened  tobaccos,  In  finecut,  ground  or  particulate  form 
or  in  any  combination  of  these  forms,  which  are  for  oral  use  other 
than  smoking;". 
2.  Article  4  is  amended  as  follows: 
(a)  Paragraph  2  is  replaced  by  the  following: 
"2.  Apart  from  the  general  warning  referred  to  in  paragraph  1, 
tobacco  product  packaging  shal I  carry specific warnings  as. follows: 
(a)  "With  regard  to cigarette packets  and  rofl ing  tobacco,  the other 
large  surface  of  the  packet  shal I  carry  specific warnings.  To  this 
end,  each  Member  State  shall  draw  up  a  list  of  warnings  taken 
exclusively  from  those  I isted  in  the  Annex;  · 
(b)  the  unit  packets  of  cigars,  cigarillos,  pipe  tobacco  or  other 
smoking  tobacco  products  with  the  exception  of  cigarettes  and 
rolling  tobacco  shall  carry,  in  add it ion  to  the  general  warning 
provided  for  in  paragraph  1,  a  specific warning.  To  this  end,  each 
Member  State shal 1  draw  up  a  list of  warnings  taken  exclusively  from 
those  I isted  in  the  Annex,  with  the  exception  of  warning  No  2  in 
part  A of  the  Annex. 
(c)  unit  packets  of  smoke I  ess  tobacco  products  sha II  carry,  in 
addition  to  the  warning  provided  for  In  paragraph  1,  the  following 
specific warning  :  "Can  cause  cancer". 
The  specific  warnings  provided  for  in  this  paragraph  shal I  be 
printed  or  irremovably  affixed  on  the  unit  packets  in  the  official 
language  or  languages  of  the  country  of  final  marketing,. In  such  a 
way  as  to  guara~tee,  in  .the  cases  referred  to  in  points  a)  and  b), 
the  appearance  in  rotation  of  each  warning  on  an  equal  quantity  of 
unit  packets,  with  a  tolerance of  5%. 
(b)  Paragraph  5  is  replaced  by  the  following: 
"(5)  Without  prejudice  to  paragraph  4,  the  general  warning  provided 
for  in  paragraph  1  and  the  specific  warning  provided  for  in 
paragraph  2  shall  be  printed  in,  or  Irremovably  affixed  to,  a 
conspicuous  pI ace  on  a  contrastIng  background  and  In  such  a  way  as 
to  be  easily  visible·,  clearly  legible  and  indelible.  The  warnings 
shall  not  in  any  way  be.  hidden,  obscured  or  Interrupted  by  other 
written or  pictorial  matter." - 16  -
3.  Article 5  Is  replaced  by  the  following: 
"Article 5 
The  Commission  shal I  adopt  the  measurement  and  verification  methods 
referred  to  In  Article  3(1)  and  (2)  In  accordance  with  the  procedure 
provided  for  In  Articles 6  and  7." 
4.  :  The  following  Article Sa  is  Inserted: 
•Article Sa 
Member  States  shall  prohibit  the  release  on  the  market  of  moist  snuff 
tobacco products  for  oral  use." 
5.  The  Annex  is amended  as set out  in  the  Annex  to  this Directive. 
Article  2 
1.  The  prohibit ion  of  moist  snuff  tobacco  products  shall  enter  Into 
force  before  1  July  1992. 
2.  For  the  other  amendments  made  by  this  Directive  to  Directive 
S9/622/EEC,  Member  States  shall  take  the  necessary  steps  to  comply 
before  1  July  1992.  They  shall  Immediately  Inform  the  Commission 
thereof  and  shall  send  to  It  the  provisions  they  have  adopted. 
When  Member  States  adopt  these  provisions,  they  shall  contain  a 
reference  to  this  Directive  or  shall  be  accompanied  by  such 
reference  at  the  time  of  their  official  publication.  The  procedure 
for  such  reference shal I  be  adopted  by  Member  States. 
3.  Member  States  shall  bring  into  force  the  provisions  referred  to  in 
paragraph  2  before  31  December  1992.  Nevertheless,  products existing 
at  that  date  which  do  not  comply  with  Article  1(2)(a)  may  still  be 
marketed until  31  December  1993. 
Article 3 
1.  The  Commission  shall  publish  the  national  lists of warnings  provided 
for  In  Article  4(2)  subparagraph  1,  point  a)  for  rolling  tobaccos 
and  point  b)  for  other  smoking  tobaccos  in  the  Official  Journal  of 
the  European  Communties. 
2.  Member  States  which,  after  31  December  1992,  modify  their  I ists of 
warnings  as  provided  for  in  Article  4(2)(a)  and  (b)  shall  notify 
this  modification  1S  months  before  its  application  to  the 
Commission,  which  shall  publish  it  in  the  Official  Journal  of  the 
European  Communities. 
Article 4 
This Directive  is  addressed  to  the Member  States. 
Done  at  Brussels,  For  the  Counc I I - 17-
ANNEX 
1.  The  title of  the Annex  to  the  Directive shall  be  worded  as  follows: 
"List  of  health  warnings  referred  to  points  a)  and  b). of 
subparagraph  1  of Article 4  (2)a  · 
2.  In  part  8  of  the  Annex,  the  following  new  warning,  No  15,  shall  be. 
added  after  warning  No  14: 
"15.  Smoking  causes addiction." TOBACCO  PRODUCTS 
IMPACT  ON-COMPETITIVENESS  AND  EMPLOYMENT 
1.  What  is the principal reason  for the measure  ? 
The  establishment  of  the  internal  market  taking  as  a  base  a 
high level of health protection. 
2.  Characteristics of the concerned enterprises.  In particular  : 
a.  Is  there  a  large  number  of  SME  ?  The  number  of  SME 
producing  cigarettes  is  rather  small.  On  the  other  hand 
there  is  a  larger  number  of  SME  producing  other  tobacco 
products,  particularly  in  Germany.  This  is also  the  case 
in the  area of distribution.  Moist  oral  snuff is produced 
by  large enterprises in third countries. 
b.  Are  there concentrations  in these regions  :  No 
eligible for regional  aide for Member  states  ?  No 
eligible for  EFRA  ?  No 
3.  What  are the obligations  imposed directly on enterprises  ? 
This  proposal  aimes  at  developing  the  dispositions  of 
directive  89/622/EEC  to establish specific advertisements  for 
tobaco  products  other  than  cigarettes  in  order  to  inform 
about the health risks connected with their consumption  : 
the  packages  of  these  products  will  carry,  besides  a  general 
warning  already  provided  by  directive  89/622/EEC,  a  specific 
warning.  The  selection  rules  for  this  warning  are  set  up  by 
the present proposal. 
It also  provides  for  the  banning  of  marketing  of  moist  oral 
snuff. 
4.  What  obligations  might  be  imposed  indirectly  on  enterprises 
by local authorities  ? 
None. 
5.  Are  there special measures  for  SME  ? 
No 6.  What  is the probable  impact  : 
a.  on  the competitiveness  of enterprises ? 
The  proposa~  establishes  a  common  set  of  rules  for  the 
marketing  of  all  concerned  products  on  community 
territory. 
It  is  very  difficult  to  predict  the  impact  of  the 
directive  on  the  demand  for  these  products.  The 
improvement  of  information  and  health  education  of 
smokers  should,  in  general,  not  have  much  impact  on  the 
European  SMEs.  The  objective of these  improved  labelling, 
however,  is  of  course  to  reduce  the  consumption  of 
tobacco products. 
b.  on  employment  ?  No  direct significant impact. 
7.  Have  the  two  sides of  industry been consulted? What  is their 
opinion  ? 
The  proposition  is  the  implementation  of  a  commitment  taken 
by  the  Commission  with  the  Council  on  the  occasion  of  the 
adoption  of  directive  89/622/EEC.  It has  been  prepared  after 
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